CClinicalTrials.gg
CompletedNCT01793493Allena-MenteUpdated Sep 13, 2023

Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia (Allena-Mente).

An interventional study of Cognitive stimulation and Sanitary education in Mild Cognitive Impairment and Healthy Subjects With Family History for Dementia, sponsored by Fondazione Golgi Cenci. Completed at 1 site in Italy. Open to participants aged 70 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-09-13.

Sponsored by Fondazione Golgi Cenci · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
121
Allocation
Randomized
Ages
70 Years to 75 Years
Sex
All
01

Study summary

The Allena-Mente study is a randomized, controlled, single-blind trial assessing the efficacy of cognitive stimulation (CS) compared to an active control group, participating to sanitary education lessons (AC). This non-pharmacological intervention is delivered to Mild Cognitive Impairment (MCI) and cognitively healthy individuals with first-degree relative with dementia (NDFAM).

Read the detailed description

The experimental protocol was set up with a pilot study on healthy elderly individuals. Data from this pilot study will be excluded from the statistical analysis.

Sample size: a priori power analysis was performed to evaluate the sample size required for the study. MCI and NDFAM were considered separately for sample size calculation. For power calculation a two-tailed test was used and a significance level (α) and test power (1-β) were set at 0.05 and 0.8/0.9, respectively.

Randomization: The individuals belonging to MCI and NDFAM subgroup were randomly assigned to CS or AC group. The randomization was performed by a statistician blind to participants characteristics using the Random Allocation Software. Allocation ratio was set at 1:1, stratification was performed for birth cohort (≤1937 and ≥1938), education level (years of education ≤5 years and >5 years).

Participants provided written informed consent before study participation.

02

Conditions studied

  • Mild Cognitive Impairment
  • Healthy Subjects With Family History for Dementia

Keywords

  • Mild Cognitive Impairment
  • Cognitive Stimulation
  • Aging
  • Elderly
  • Randomized Controlled Trial
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's enrollment of 121 is above the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Fondazione Golgi Cenci is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Positive diagnosis for mild cognitive impairment (MCI) according to Petersen's criteria;
  • Cognitively healthy elderly individuals, having at least one first-degree relative affected by dementia (Alzheimer's Disease, pre-senile and senile dementia, vascular dementia) (NDFAM).

Exclusion criteria

Exclusion Criteria:

  • (Major physical illness) Compromission of motor performance of lower and upper limbs
  • Medical conditions leading to clinical instability;
  • Therapies that reduce cognitive and communicative abilities and consciousness;
  • Perceptual disorders (sight, hearing)
  • Language disorders
  • Education level lower than 3 years
  • Psychiatric and behavioral disorders
  • Addiction to drugs or alcohol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
121 participants (actual)

Study arms

  • Experimental
    Cognitive stimulation

    Other: Cognitive stimulation

  • Active comparator
    Sanitary education

    Other: Sanitary education

Interventions

  • OtherCognitive stimulation

    Participants are pooled in small groups (6-8 individuals). Each group participates to ten twice weekly meetings. Each CS session is run by one trained operator. One observer participates to the sessions to guarantee homogeneity between different operators. Exercises are structured with an increasing cognitive complexity and are tailored to the characteristics of the group. Meetings (each lasting about 2 hours) have a common structure: * body awakening (10 minutes) * cognitive stimulation (1 hour and a half) scheduled as follow: * temporospatial orientation * attentional abilities * one of the following cognitive areas: language, executive functions, verbal and visual memory (encoding, consolidation, retrieval)

  • OtherSanitary education

    Participants attend two weekly meetings (for a total of 3 hours) focused on lifestyle education and brain functioning.

06

What researchers measure

Primary outcomes

  1. Long-term change from Baseline in Mini Mental State Examination (MMSE)

    Mini Mental State examination (MMSE) is a brief test of mental status and cognitive function, commonly used in clinical research to screen global cognitive functioning.

    Time frame: baseline and up to 4 years

Secondary outcomes

  1. Change from Baseline in Mini Mental State Examination at 2-weeks after the intervention

    MMSE is a brief test of mental status and cognitive function, commonly used in clinical research to screen global cognitive functioning.

    Time frame: baseline, two-weeks after the intervention

  2. Change from Baseline in Montreal Cognitive Assessment (MoCA) at 2-weeks after the intervention

    MoCA is a brief cognitive screening tool with a high sensitivity and specificity for detecting MCI in individuals performing in the normal range on the MMSE (avoiding ceiling effect).

    Time frame: baseline, two-weeks after the intervention

  3. Change from Baseline in Corsi test at 2-weeks after the intervention

    Corsi test evaluates visual-spatial short-term memory. We used this test to implement non-verbal memory in our neuropsychological test battery

    Time frame: baseline, two-weeks after the intervention

  4. Change from Baseline in Walking While Talking Dual Task at 2-weeks after the intervention

    Walking speed measures the ability to perform a dual action task. Single task: participants walk back and forth along an indicated distance of 5 meters with no pausing. Dual task: participants perform the same movement as in the single task while listing personal names in a loud voice (female names for men and male names for women) The span between time needed to perform the dual and the single task is registered.

    Time frame: baseline, two-weeks after the intervention

07

Study locations

1 site
  • Golgi Cenci Foundation
    Abbiategrasso, Milan 20081, Italy
08

References and documents

Publications

  • Polito L, Abbondanza S, Vaccaro R, Valle E, Davin A, Degrate A, Villani S, Guaita A. Cognitive stimulation in cognitively impaired individuals and cognitively healthy individuals with a family history of dementia: short-term results from the "Allena-Mente" randomized controlled trial. Int J Geriatr Psychiatry. 2015 Jun;30(6):631-8. doi: 10.1002/gps.4194. Epub 2014 Sep 3. PubMed 25187003 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01793493
Lead sponsor
Fondazione Golgi Cenci
Collaborators
Alzheimer Federation Italy, Camillo Golgi Geriatric Institute, University of Pavia, Mario Negri Institute for Pharmacological Research
Responsible party
Antonio Guaita, MD (MD, Fondazione Golgi Cenci) — Principal investigator
First posted
Feb 15, 2013
Start date
Mar 2011
Primary completion
Mar 2015
Completion
Jun 2015
Last update
Sep 13, 2023

Study contacts

Antonio Guaita, MD
study director · GolgiCenci Foundation

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion